WINSTON ANDRE VADINO
Pharmacy in White House Station, NJ

License number
Pennsylvania RP026201L
Category
Pharmacy
Type
Pharmacist
Address
Address 2
White House Station, NJ 08889
Pennsylvania
LicenseFiles verified this license of Apr 21, 2017 at the Pennsylvania Licensing System.

Personal information

See more information about WINSTON ANDRE VADINO at radaris.com
Name
Address
Phone
Winston Vadino
9 Glenmont Rd, Whitehouse Station, NJ 08889
Winston A. Vadino
Cresco, PA
(570) 595-7239
Winston Vadino
9 Glenmont Rd, Whitehouse Station, NJ 08889

Professional information

Winston Vadino Photo 1

Orally Administrable Solid Ribavirin Dosage Forms And Process For Making Them

US Patent:
6337090, Jan 8, 2002
Filed:
Nov 13, 2000
Appl. No.:
09/582060
Inventors:
Stephen M. Liebowitz - Neshanic Station NJ
Elliot I. Stupak - West Caldwell NJ
Imtiaz A. Chaudry - North Caldwell NJ
Winston A. Vadino - Whitehouse Station NJ
Frank E. Bowen - Rutherford NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 948
US Classification:
424451, 424452, 424461, 514383, 514384
Abstract:
An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0. 6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin and a process for making such solid dosage forms are disclosed.

Winston Vadino Photo 2

Orally Administrable Solid Dosage Form

US Patent:
6335032, Jan 1, 2002
Filed:
Mar 6, 2000
Appl. No.:
09/518871
Inventors:
Stephen M. Liebowitz - Neshanic Station NJ
Elliot I. Stupak - West Caldwell NJ
Imtiaz A. Chaudry - North Caldwell NJ
Winston A. Vadino - Whitehouse Station NJ
Frank E. Bowen - Rutherford NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 948
US Classification:
424451, 424452, 424461, 514383, 514384
Abstract:
An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0. 6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin is disclosed.

Winston Vadino Photo 3

Orally Administrable Solid Dosage Form

US Patent:
5914128, Jun 22, 1999
Filed:
Dec 22, 1997
Appl. No.:
8/997172
Inventors:
Stephen M. Liebowitz - Neshanic Station NJ
Elliot I. Stupak - West Caldwell NJ
Imtiaz A. Chaudry - North Caldwell NJ
Winston A. Vadino - Whitehouse Station NJ
Frank E. Bowen - Rutherford NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 948, A61K 962, A61K 3141
US Classification:
424451
Abstract:
An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0. 6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin is disclosed.

Winston Vadino Photo 4

Controlled-Release Dosage Form Comprising Acetaminophen, Pseudoephedrine And Dexbrompheniramine

US Patent:
4777050, Oct 11, 1988
Filed:
Mar 23, 1987
Appl. No.:
7/029032
Inventors:
Winston A. Vadino - Whitehouse Station NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 3174, A61K 920, A61K 922
US Classification:
424468
Abstract:
The invention relates to a controlled release dosage form comprising three actives: acetaminophen, pseudoephedrine and dexbrompheniramine.

Winston Vadino Photo 5

Pharmaceutical Composition Comprising Loratadine, Ibuprofen And Pseudoephedrine

US Patent:
4990535, Feb 5, 1991
Filed:
May 3, 1989
Appl. No.:
7/346687
Inventors:
Wing-Kee P. Cho - Princeton NJ
Winston A. Vadino - Whitehouse Station NJ
Imtiaz A. Chaudry - Denville NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 3119, A61K 31205
US Classification:
514556
Abstract:
Pharmaceutical compositions for use in the treatment of cough/cold symptoms comprising loratadine, ibuprofen and pseudoephedrine are disclosed.

Winston Vadino Photo 6

Long Acting Diltiazem Formulation

US Patent:
5000962, Mar 19, 1991
Filed:
Aug 25, 1989
Appl. No.:
7/398209
Inventors:
Surendra Sangekar - Union NJ
Winston A. Vadino - Whitehouse Station NJ
Eugenio A. Cefali - Plantation FL
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 932
US Classification:
424482
Abstract:
A long acting diltiazem formulation is disclosed that comprises more than 35 percent by weight of a swellable hydrophilic polymer. Release rate is also controlled by the application of diffusion controlled membrane to the matrix tablet containing swellable hydrophilic polymers. The diffusion rate through the membrane depends upon the composition or ratio of hydrophilic to hydrophobic coating agent.

Winston Vadino Photo 7

Oral Antifungal Composition

US Patent:
5846971, Dec 8, 1998
Filed:
Jun 20, 1997
Appl. No.:
8/879928
Inventors:
Surendra A. Sangekar - Union NJ
Winston A. Vadino - Whitehouse Station NJ
Ping I. Lee - Radnor PA
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31495, A61K 31675, A61K 3154, A61K 31535
US Classification:
514252
Abstract:
A pharmaceutical composition comprising: i) substantially inert beads; wherein said beads are coated with ii) an antifungal agent which is (-)-(2R-cis)-4-�4-�4-�4-��-5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-tr iazol-1-ylmethyl)furan-3-yl!methoxy!phenyl!-1-piperazinyl!phenyl!-2,4-dihyd ro-2-�(S)-1-ethyl-2(S)-hydroxypropyl!-3H-1,2,4-triazol-3-one; iii) a binder to enables the antifungal compound to adhere to said beads. The composition enables the antifungal compound, which has very low water solubility, to have enhanced bioavailability in mammals, such as humans.

Winston Vadino Photo 8

Sustained Release Tablet Comprising Loratadine, Ibuprofen And Pseudoephedrine

US Patent:
5100675, Mar 31, 1992
Filed:
Nov 13, 1990
Appl. No.:
7/612633
Inventors:
Wing-Kee P. Cho - Princeton NJ
Winston A. Vadino - Whitehouse Station NJ
Imtiaz A. Chaudry - Denville NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A01N 3730, A01N 3700, A61K 922
US Classification:
424468
Abstract:
Pharmaceutical compositions for use in the treatment of cough/cold symptoms comprising loratadine, ibuprofen and pseudoephedrine are disclosed.

Winston Vadino Photo 9

Process Of Making Solid Ribavirin Dosage Forms

US Patent:
5916594, Jun 29, 1999
Filed:
Dec 22, 1997
Appl. No.:
8/997169
Inventors:
Stephen M. Liebowitz - Neshanic Station NJ
Elliot I. Stupak - West Caldwell NJ
Imtiaz A. Chaudry - North Caldwell NJ
Winston A. Vadino - Whitehouse Station NJ
Frank E. Bowen - Rutherford NJ
Assignee:
Schering Corporation
International Classification:
A61K 920, A61K 948
US Classification:
424465
Abstract:
A process of making an orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0. 6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin as determined is disclosed.

Winston Vadino Photo 10

Sustained Release Labetalol Tablets

US Patent:
4940580, Jul 10, 1990
Filed:
Feb 2, 1989
Appl. No.:
7/306253
Inventors:
Surendra Sangekar - New York NY
Winston A. Vadino - Whitehouse Station NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 3179, A01N 3736
US Classification:
424 80
Abstract:
A sustained release dosage form of labetalol hydrochloride is disclosed comprising the active ingredient in a polymeric matrix of hydroxypropylmethylcellulose and polyvinylpyrrolidone and a pharmaceutically acceptable organic acid.

Pharmacy licenses in Pennsylvania










Other Doctors licenses in Pennsylvania